Molecular diagnosis of chronic granulomatous disease

Clinical and Experimental Immunology

Volumn 175, Issue 2, 2014, Pages 139-149

  Roos, D ^a   de Boer, M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

CGD; DHR test; Mutation analysis; NADPH oxidase; NBT test

Indexed keywords

COTRIMOXAZOLE; HYDROGEN PEROXIDE; ITRACONAZOLE; NITROBLUE TETRAZOLIUM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ARTICLE; ASSAY; CELL FREE SYSTEM; CHRONIC GRANULOMATOUS DISEASE; COMPARATIVE GENOMIC HYBRIDIZATION; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; GENE SEQUENCE; GENETIC TRANSFECTION; HETEROZYGOTE DETECTION; HUMAN; INFECTIOUS COMPLICATION; MEASUREMENT; MOLECULAR DIAGNOSIS; MUTATIONAL ANALYSIS; NONHUMAN; OXYGEN CONSUMPTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING; WESTERN BLOTTING;

CGD; DHR TEST; MUTATION ANALYSIS; NADPH OXIDASE; NBT TEST;

BACTERIAL INFECTIONS; BASE SEQUENCE; FEMALE; GENE EXPRESSION; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; HYDROGEN PEROXIDE; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR SEQUENCE DATA; MUTATION; MYCOSES; NADPH OXIDASE; PHAGOCYTES; PRENATAL DIAGNOSIS; SEQUENCE ANALYSIS, DNA; SUPEROXIDES;

EID: 84891612200     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12202     Document Type: Article

References (40)

1. Roos D, Holland SM, Kuijpers TW. Chronic granulomatous disease. In: Ochs HD, Smith CIE, Puck JM, eds. Primary immunodeficiency diseases. A molecular and genetic approach, 3rd edn. New York: Oxford University Press, 2013. in press.
2. Reeves EP, Lu H, Jacobs HL etal. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 2002; 416:291-297.
3. -/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease. J Clin Invest 1998; 101:1843-1850.
4. Messina CG, Reeves EP, Roes J, Segal AW. Catalase-negative Staphylococcus aureus retain virulence in mouse model of chronic granulomatous disease. FEBS Lett 2002; 518:107-110.
5. Köker MY, Camcioǧlu Y, Van Leeuwen K etal. Clinical, functional and genetic characterization of eighty-nine patients in Turkey with chronic granulomatous disease. J Allergy Clin Immunol 2013; 132:1156-1163.
6. Kuhns DB, Alvord WG, Heller T etal. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 2010; 363:2600-2610.
7. Ho CML, Vowels MR, Lockwood L, Ziegler JB. Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease. Bone Marrow Transplant 1996; 18:213-215.
8. Seger RA, Gungor T, Belohradsky BH etal. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hematopoietic allograft: a survey of the European experience 1985-2000. Blood 2002; 100:4344-4350.
9. Åhlin A, Fugeläng J, de Boer M, Ringden O, Fasth A, Winiarski J. Chronic granulomatous disease - haematopoietic stem cell transplantation versus conventional treatment. Acta Paediatr 2013; 102:1087-1094.
10. Ott MG, Schmidt M, Schwarzwälder K etal. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006; 12:401-409.
11. Malech HL, Maples PB, Whiting-Theobald N etal. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc Natl Acad Sci USA 1997; 94:12133-12138.
12. Roos D, de Boer M. Purification and cryopreservation of phagocytes from human blood. Meth Enzymol 1986; 132:225-243.
13. Weening RS, Roos D, Loos JA. Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations: a comparative study. J Lab Clin Med 1974; 83:570-577.
14. Elloumi HZ, Holland SM. Diagnostic assays for chronic granulomatous disease and other neutrophil disorders. Methods Mol Biol 2007; 412:505-523.
15. Meerhof LJ, Roos D. Heterogeneity in chronic granulomatous disease detected with an improved nitroblue tetrazolium slide test. J Leukoc Biol 1986; 39:699-711.
16. Roesler J. Remarks on the article Genetics and immunopathology of chronic granulomatous disease by Marie José Stasia and Xing Jun Li. Semin Immunopathol 2008; 30:365.
17. Dahlgren C, Karlsson A, Bylund J. Measurement of respiratory burst products generated by professional phagocytes. Methods Mol Biol 2007; 412:349-363.
18. Emmendörffer A, Nakamura M, Rothe G, Spiekermann K, Lohmann-Matthes M-L, Roesler J. Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions. Cytometry 1994; 18:147-155.
19. Van Pelt LJ, van Zwieten R, Weening RS, Roos D, Verhoeven AJ, Bolscher BG. Limitations on the use of dihydrorhodamine-1, 2, 3 for flow cytometric analysis of the neutrophil respiratory burst. J Immunol Methods 1996; 191:187-196.
20. Vowells SJ, Fleisher TA, Sekhsaria S, Alling DW, Maguire TE, Malech HL. Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr 1996; 128:104-107.
21. Mauch L, Lun A, O'Gorman MRG etal. Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD. Clin Chem 2007; 53:890-896.
22. phox. Microbiol Immunol 2001; 45:249-257.
23. Köker MY, Sanal O, van Leeuwen K etal. Four different NCF2 mutations in six families from Turkey and an overview of NCF2 gene mutations. Eur J Clin Invest 2009; 39:942-951.
24. Matute JD, Arias AA, Wright NA etal. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 2009; 114:3309-3315.
25. Ambruso DR, Knall C, Abell AN etal. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci USA 2000; 97:4654-4659.
26. Van Bruggen R, Bautista JM, Petropoulou T etal. Deletion of leucine-61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 2002; 100:1026-1030.
27. Molshanski-Mor S, Mizrahi A, Ugolev Y, Dahan I, Berdichevsky Y, Pick E. The reductionist approach to the study of NADPH oxidase assembly, or 'all you wanted to know about cell-free assays but did not dare to ask'. Methods Mol Biol 2007; 412:385-428.
28. phox cDNA. Proc Natl Acad Sci USA 1992; 89:10174-10177.
29. Dekker J, de Boer M, Roos D. Gene-scan method for the recognition of carriers and patients with p47-phox-deficient autosomal recessive chronic granulomatous disease. Exp Hematol 2001; 29:1319-1325.
30. phox component of the phagocyte NADPH oxidase. Hum Mutat 2006; 27:1218-1229.
31. Patiño PJ, Perez JE, Lopez JA etal. Molecular analysis of chronic granulomatous disease caused by defects in gp91-phox. Human Mutat 1999; 13:29-37.
32. Di Matteo G, Giordani L, Finocchi A etal. Molecular characterization of a large cohort of patients with chronic granulomatous disease and identification of novel CYBB mutations: an Italian multicenter study. Mol Immunol 2009; 46:1935-1941.
33. Hill HR, Augustine NH, Pryor RJ etal. Rapid genetic analysis of X-linked chronic granulomatous disease by high-resolution melting. J Mol Diagn 2010; 12:368-376.
34. Breunis WB, van Mirre E, Bruin M etal. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood 2008; 111:1029-1038.
35. Shinawi M, Cheung SW. The array CGH and its clinical applications. Drug Discov Today 2008; 13:760-770.
36. Stasia MJ, van Leeuwen K, de Boer M etal. Rare duplication or deletion of exons 6, 7 and 8 in CYBB leading to X-linked chronic granulomatous disease in two patients from different families. J Clin Immunol 2012; 32:653-662.
37. Stasia MJ, Mollin M, Martel C etal. Functional and genetic characterization of two extremely rare cases of Williams-Beuren syndrome associated with chronic granulomatous disease. Eur J Hum Genet 2013; 21:1079-1084.
38. Newburger PE, Cohen HJ, Rothchild SB, Hobbins JC, Malawista SE, Mahoney MJ. Prenatal diagnosis of chronic granulomatous disease. N Engl J Med 1979; 300:178-181.
39. De Boer M, Bolscher BGJM, Sijmons RH, Scheffer H, Weening RS, Roos D. Prenatal diagnosis in a family with X-linked chronic granulomatous disease with the use of the polymerase chain reaction. Prenat Diagn 1992; 12:773-777.
40. De Boer M, Singh V, Dekker J, Di Rocco M, Goldblatt D, Roos D. Prenatal diagnosis in two families with autosomal, p47-phox-deficient chronic granulomatous disease due to a novel point mutation in NCF1. Prenat Diagn 2002; 22:235-240.